Results 191 to 200 of about 107,429 (283)

Success rate and obstetric outcomes of trial of labor after cesarean delivery—Decision‐tree analysis

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Background Pregnant women with a previous cesarean delivery (CD) may opt for a trial of labor after cesarean (TOLAC) or elective repeat cesarean delivery (ERCD). This study aimed to evaluate the success rate, and maternal, and perinatal outcomes of TOLAC and to develop a predictive decision‐tree algorithm for successful TOLAC.
Ohad Houri, Or Bercovich, Alexandra Berezovsky, Shir Danieli Gruber, Anat Pardo, Avital Werthimer, Asnat Walfisch, Eran Hadar   +7 more
wiley   +1 more source

Provision of information, secondary stroke prevention and holistic care for post-transient ischemic attack patients: A scoping review. [PDF]

Medicine (Baltimore)
Ho WS, Mohd Nordin NA, Abdul Aziz AF.
europepmc   +1 more source

Preterm meconium‐stained amniotic fluid: A red flag for infection and adverse perinatal outcomes

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective Meconium‐stained amniotic fluid (MSAF) is uncommon in preterm deliveries and raises concerns about maternal and neonatal infectious risks. We aimed to evaluate maternal, perinatal, and microbiological outcomes in preterm deliveries complicated by MSAF compared to clear amniotic fluid (AF) and to assess outcomes in preterm versus term
Raneen Abu Shqara, Neta Hoffman, Lior Lowenstein, Maya Frank Wolf   +3 more
wiley   +1 more source

Long-Term Outcomes in Patients With Hemorrhagic Moyamoya Disease Combined With Hypertension After Encephaloduroarteriosynangiosis. [PDF]

J Am Heart Assoc
Guo Q, Xie M, Ji H, Wang QN, Bao X, Duan L.   +5 more
europepmc   +1 more source

Mitochondrial dysfunction: Related diseases, influencing factors, and detection

Interdisciplinary Medicine, EarlyView.
Mitochondrial dysfunction is implicated in the pathogenesis of numerous diseases, including neurological disorders, cancers, and cardiovascular conditions, through mechanisms such as mitochondrial DNA mutations, dysregulation of mitochondrial network dynamics, and impaired mitophagy.
Zhaojin Li, Shiyu Li, Wanying Chen, Ziyu Zhang, Chun Pan, Peng Lei, Cheng Cheng, Junyou Zhu, Hanxiao Sun, Zhenning Dai   +9 more
wiley   +1 more source

Predictive value of magnetic resonance angiography combined with serum ischemia-modified albumin for secondary cerebral infarction after transient ischemic attack. [PDF]

Thromb J
Liu L, Yan Q, Ai J, Jiao R, Li M.
europepmc   +1 more source

Nanomaterials for promoting axon regeneration after spinal cord injury: Mechanisms and prospects

Interdisciplinary Medicine, EarlyView.
The effects of clinical therapies for spinal cord injury (SCI) are greatly limited due to poor axon regeneration. This review systematically discusses the ability of nanomaterials (NMs) to treat SCI and the mechanism underlying their therapeutic effects. The properties of NMs that are conducive to axon regeneration after SCI are outlined.
Jia Liu, Zhendong Huang, Xiner Tan, Wei Du, Ziyang Wang, Xinru Zhou, Hao Pan, Lili Chen, Yiyuan Kang, Longquan Shao   +9 more
wiley   +1 more source

An Unusual Cause of Transient Ischemic Attack

Canadian Respiratory Journal, 2013
Matthew J Brooks, Liam M Hannan, AiVee Ng, Louis Irving, Anu Aggarwal   +4 more
doaj   +1 more source

Diagnostic yield of standardized screening for deep venous thrombosis in patients with acute cerebral ischemia and cardiac right-to-left shunt. [PDF]

Neurol Res Pract
Michael KM, Pallesen LP, Kaiser DPO, Siepmann T, Barlinn J, Sedghi A, Weiss N, Weise M, Werth S, Barlinn K, Puetz V.   +10 more
europepmc   +1 more source

Chinese herbal medicine‐derived extracellular vesicle‐like particles: Therapeutic potential and future research approaches

Interdisciplinary Medicine, EarlyView.
This article evaluates the therapeutic potential of extracellular vesicle‐like particles derived from Chinese herbal medicine (CHM‐EVLP) for a range of diseases. It underscores the significance of traditional Chinese medicine in the development of innovative formulations.
Ying‐qi Cao, Zheng‐ting Wu, Qi You, Yuan‐yuan Xia, Qing Zhao, Carine de Marcos Lousa, Ke‐wei Zhao   +6 more
wiley   +1 more source